Panaccione R - Search Results

1

Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.

Panaccione R, Fedorak RN, Aumais G, Bernstein CN, Bitton A, Croitoru K, Enns R, Feagan B, Fishman M, Greenberg G, Griffiths A, Marshall JK, Rasul I, Sadowski D, Seidman E, Steinhart H, Sutherland L, Walli E, Wild G, Williams CN, Zachos M; Canadian Association of Gastroenterology. Panaccione R, et al. Can J Gastroenterol. 2004 Aug;18(8):503-8. doi: 10.1155/2004/670161. Can J Gastroenterol. 2004. PMID: 15372114 No abstract available.

2

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.

Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Ricart E, et al. Among authors: panaccione r. Am J Gastroenterol. 2001 Mar;96(3):722-9. doi: 10.1111/j.1572-0241.2001.03612.x. Am J Gastroenterol. 2001. PMID: 11280541

3

Infliximab for the treatment of Crohn's disease: review and indications for clinical use in Canada.

Panaccione R; Canadian Consensus Group on the use of infliximab in Crohn's disease. Panaccione R, et al. Can J Gastroenterol. 2001 Jun;15(6):371-5. doi: 10.1155/2001/490921. Can J Gastroenterol. 2001. PMID: 11429666 Review.

4

Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept--a tumour necrosis factor-alpha antagonist.

Nash CL, Panaccione R, Sutherland LR, Meddings JB. Nash CL, et al. Among authors: panaccione r. Can J Gastroenterol. 2001 Sep;15(9):607-11. doi: 10.1155/2001/954340. Can J Gastroenterol. 2001. PMID: 11573104

5

Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.

Feagan BG, Enns R, Fedorak RN, Panaccione R, Paré P, Steinhart AH, Wild G. Feagan BG, et al. Among authors: panaccione r. Can J Clin Pharmacol. 2001 Winter;8(4):188-98. Can J Clin Pharmacol. 2001. PMID: 11743591 Review.

6

Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.

Topstad DR, Panaccione R, Heine JA, Johnson DR, MacLean AR, Buie WD. Topstad DR, et al. Among authors: panaccione r. Dis Colon Rectum. 2003 May;46(5):577-83. doi: 10.1007/s10350-004-6611-4. Dis Colon Rectum. 2003. PMID: 12792431

7

The ultimate therapeutic goal: establishing and maintaining quality of life.

Panaccione R. Panaccione R. Can J Gastroenterol. 2004 Jul;18(7):465-6. doi: 10.1155/2004/569262. Can J Gastroenterol. 2004. PMID: 15229750 No abstract available.

8

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.

Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P. Hanauer SB, et al. Among authors: panaccione r. Gastroenterology. 2006 Feb;130(2):323-33; quiz 591. doi: 10.1053/j.gastro.2005.11.030. Gastroenterology. 2006. PMID: 16472588 Clinical Trial.

9

The approach to dysplasia surveillance in inflammatory bowel disease.

Panaccione R. Panaccione R. Can J Gastroenterol. 2006 Apr;20(4):251-3. doi: 10.1155/2006/693927. Can J Gastroenterol. 2006. PMID: 16609751 Free PMC article. Review. No abstract available.

10

Hematopoietic cell transplantation for Crohn's disease; is it time?

Leung Y, Geddes M, Storek J, Panaccione R, Beck PL. Leung Y, et al. Among authors: panaccione r. World J Gastroenterol. 2006 Nov 7;12(41):6665-73. doi: 10.3748/wjg.v12.i41.6665. World J Gastroenterol. 2006. PMID: 17075981 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters